Cell Growth and Survival
细胞生长和存活
基本信息
- 批准号:7529427
- 负责人:
- 金额:$ 1.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-11 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsAntiviral ResponseApoptosisApoptoticAppointmentAreaBasic ScienceBiochemistryBioinformaticsBiological MarkersBiologyBiostatistics CoreBrain NeoplasmsBreastBreast Cancer TreatmentCancer BiologyCancer Cell GrowthCancer CenterCancer ControlCell DeathCell ProliferationCell Proliferation RegulationCellsCessation of lifeClinical ResearchClinical TrialsCollaborationsColoradoComplementary and alternative medicineComprehensive Cancer Center of Wake Forest UniversityComputational BiologyCore FacilityCultured CellsDNA SequenceData AnalysesDendritic CellsDevelopmentDietary FactorsDietary FatsDietary InterventionDirect CostsElectron Microscopy FacilityEmployee StrikesEndoplasmic ReticulumEnzymesEpidemiologic StudiesEpithelial CellsFacultyFluorescenceFocus GroupsFundingGene ExpressionGenerationsGenesGeneticGenetic PolymorphismGenomicsGliomaGoalsGrowthHeart DiseasesHumanHypoxiaImmuneImmune responseImmunityImmunologic SurveillanceImmunologistIndiumInduction of ApoptosisInflammationInflammatoryInstitutesInvestigationIrisIsoflavonesLaboratoriesLeadLeadershipLeftLinkLipidsMalignant NeoplasmsMalignant neoplasm of prostateMass Spectrum AnalysisMathematicsMediatingMetabolismMicroscopyModelingModificationMolecular TargetMusMutant Strains MiceNatural ImmunityNeoplasm MetastasisOncolytic virusesOxidation-ReductionOxygenOxygen measurement, partial pressure, arterialPathway interactionsPatientsPeer ReviewPhosphoric Monoester HydrolasesPlatelet Activating FactorPlayPolyunsaturated Fatty AcidsPositioning AttributePost-Translational Protein ProcessingPredispositionPreventionPrimatesProcessProductionProductivityProstateProstaticProtein AnalysisProteinsProteomicsPublishingRadiation therapyRadiosensitizationReactive Oxygen SpeciesRecombinantsRecruitment ActivityRegulationReportingResearchResearch PersonnelResearch Project GrantsResistanceResourcesRiskRodent ModelRoleSamplingSeriesSignal PathwaySignal TransductionSignaling MoleculeSolid NeoplasmSpecimenStandards of Weights and MeasuresStressSystems BiologyT-LymphocyteTechnologyTherapeuticThinkingTimeToll-like receptorsTranscriptional RegulationTranslatingTranslational ResearchTranslationsTumor TissueUniversitiesViral GenomeViral VectorVirginiaVirusVirus AssemblyVirus DiseasesVitamin DVitamin D AnalogWorkZemplaranticancer researchbasebench to bedsidebiological adaptation to stresscancer cellcancer therapycell growthcell growth regulationcell injurychemotherapeutic agentcomputer scienceconceptcysteinesulfenic acidfascinateforestimprovedinterestkillingslycopenemalignant breast neoplasmmedical schoolsmembermultidisciplinarymutantneoplastic cellnovelnovel strategiesoutcome forecastprofessorprogramsprohormonerapid growthsoysoy protein isolatesuccesssynergismtraittranscription factortumortumorigenesisvirus host interaction
项目摘要
The Cell Growth and Survival (CGS) Program is focused on the signaling pathways that regulate the growth,
survival and death of normal and neoplastic cells. The goal of this research is to develop novel strategies
that exploit this understanding to improve anti-cancer therapy. The CGS Program currently has 27 scientific
members from 10 departments in the Wake Forest University School of Medicine. Changes in membership
of the CGS program since the previous review in 2000 reflect specific, targeted recruiting to improve
integration of the major themes of the program. These changes are now paying dividends in terms of
scientific productivity. This program has undergone substantial growth in its total funding, from $2.44M to
S4.38M direct costs in annual peer-reviewed funding. In addition, the extent of scientific collaboration has
increased markedly during the present funding period, centered on the major themes of the Program. CGS
Program members published 242 peer-reviewed articles in 2001-2005. Of these, 20% had at least two CGS
program members as coauthors, compared to 5% in the review in 2000. In 2004, Dr. Douglas Lyles,
Professor and Chair of Biochemistry, was appointed as Director of the CGS Program (the previous director,
Dr. Thorburn, left to assume a cancer center leadership position at University of Colorado). Dr. Lyles has
been a member of the CCCWFU for 26 years. His research on virus assembly and virus-host interactions
has led to new ideas for the development of novel oncolytic viruses for the treatment of cancer. He assumed
the chairmanship of the Department of Biochemistry in 2004 with a strong commitment to recruit new faculty
in cancer research and to continue to strengthen the substantial existing relationship between the
Department of Biochemistry and the CCCWFU. Dr. Lyles' appointment has further integrated efforts in
faculty development within this program. The following sections highlight selected major themes in the CGS
program. Several novel contributions from the CGS Program to the national cancer effort have emerged as
themes since the previous review. They are: 1) a fascinating synergy between vitamin D and dietary soy
isoflavones in regulation of proliferation in prostate and breast cancer; 2) explorations of the effects of dietary
lipids on cancer cell proliferation and metastasis; 3) a novel role of reactive oxygen species as signaling
molecules in cell proliferation; 4) translational control and endoplasmic reticulum stress in hypoxia, 5) the
genetic control of innate anti-tumor immune mechanisms; and 6) the antagonistic relationship of antiviral and
proliferative signaling and the development of novel oncolytic viruses. These themes directly reflect the
value-added as a result of the CCCWFU: thematic development and faculty recruiting by the Cancer Center
leadership; shepherding the development of these themes by the Program Director; a high degree of
collaboration within the CGS and with other Programs, major participation in the Centers of Excellence, and
effective use of shared facilities.
细胞生长和存活 (CGS) 计划专注于调节生长的信号通路,
正常细胞和肿瘤细胞的存活和死亡。这项研究的目标是制定新颖的策略
利用这种理解来改善抗癌治疗。 CGS 计划目前有 27 项科学
成员来自维克森林大学医学院的 10 个系。成员资格的变化
自 2000 年上次审查以来 CGS 计划的进展反映了具体的、有针对性的招募,以改善
计划的主要主题的整合。这些变化现在正在带来红利
科学生产力。该计划的总资金大幅增长,从 244 万美元增加到
S4.38M 年度同行评审资金的直接成本。此外,科学合作的程度
在当前供资期间,围绕该计划的主要主题显着增加。中国地质调查局
2001 年至 2005 年期间,计划成员发表了 242 篇同行评审文章。其中,20% 至少拥有两项 CGS
计划成员作为共同作者,而 2000 年审查中的比例为 5%。2004 年,Douglas Lyles 博士,
教授兼生物化学系主任,被任命为CGS项目主任(前任主任,
Thorburn 博士,离开后担任科罗拉多大学癌症中心的领导职务)。莱尔斯博士有
成为 CCCWFU 会员已 26 年。他对病毒组装和病毒与宿主相互作用的研究
引发了开发用于治疗癌症的新型溶瘤病毒的新想法。他假设
2004年担任生物化学系系主任,坚定致力于招募新教师
癌症研究并继续加强之间的实质性现有关系
生物化学系和CCCWFU。莱尔斯博士的任命进一步整合了以下方面的努力:
该计划内的教师发展。以下部分重点介绍 CGS 中选定的主要主题
程序。 CGS 计划对国家癌症工作做出的几项新贡献如下:
自上次审查以来的主题。它们是:1) 维生素 D 和食用大豆之间令人着迷的协同作用
异黄酮调节前列腺癌和乳腺癌的增殖; 2)饮食影响的探索
脂质对癌细胞增殖和转移的影响; 3)活性氧作为信号传导的新作用
细胞增殖中的分子; 4)缺氧时的翻译控制和内质网应激,5)
先天抗肿瘤免疫机制的遗传控制; 6)抗病毒药物和抗病毒药物的拮抗关系
增殖信号传导和新型溶瘤病毒的开发。这些主题直接反映了
CCCWFU 带来的增值:癌症中心的主题开发和教师招聘
领导;由项目主任引导这些主题的发展;高度
CGS 内部以及与其他计划的合作,主要参与卓越中心,以及
有效利用共享设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS S. LYLES其他文献
DOUGLAS S. LYLES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS S. LYLES', 18)}}的其他基金
RNA-Binding Proteins and Host Shut-Off by VSV
RNA 结合蛋白和 VSV 关闭宿主
- 批准号:
8812772 - 财政年份:2014
- 资助金额:
$ 1.58万 - 项目类别:
RNA-Binding Proteins and Host Shut-Off by VSV
RNA 结合蛋白和 VSV 关闭宿主
- 批准号:
9020822 - 财政年份:2014
- 资助金额:
$ 1.58万 - 项目类别:
Structural and Computational Biophysics Training Program
结构和计算生物物理学培训计划
- 批准号:
8284302 - 财政年份:2011
- 资助金额:
$ 1.58万 - 项目类别:
Structural and Computational Biophysics Training Program
结构和计算生物物理学培训计划
- 批准号:
8691895 - 财政年份:2011
- 资助金额:
$ 1.58万 - 项目类别:
Structural and Computational Biophysics Training Program
结构和计算生物物理学培训计划
- 批准号:
8017859 - 财政年份:2011
- 资助金额:
$ 1.58万 - 项目类别:
Structural and Computational Biophysics Training Program
结构和计算生物物理学培训计划
- 批准号:
8881216 - 财政年份:2011
- 资助金额:
$ 1.58万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 1.58万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 1.58万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 1.58万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 1.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 1.58万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 1.58万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 1.58万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 1.58万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 1.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 1.58万 - 项目类别:














{{item.name}}会员




